Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 66 clinical trials
featured
Migraine (Pediatric)

To evaluate the efficacy and safety of zolmitriptan nasal spray (ZNS) in the acute treatment of migraine headache in subjects ages 6 to 11 years. Eligibility Criteria:

acute migraine
nasal spray
headache
acute treatment
  • 212 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents.

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of

  • 316 views
  • 07 Nov, 2020
  • 1 location
featured
A Randomized, Multicenter, Double-Blind, Flexibly-dosed, Efficacy and Safety Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder

The primary objective of this study is to assess the safety and efficacy of escitalopram relative to placebo in the acute treatment of children (aged 7 through 11 years) and

  • 65 views
  • 23 Nov, 2020
  • 1 location
Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine

This trial is to determine whether BHV3000 (rimegepant) 75mg is safe and effictive as a treatment for acute migraine in Chinese and Korean patients

  • 0 views
  • 15 Jan, 2021
  • 86 locations
An Open-Label Phase 3 Study to Examine the Long-Term Safety Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

mini-mental state examination
dopa
hoehn and yahr scale
carbidopa
levodopa
  • 104 views
  • 02 Apr, 2020
  • 1 location
Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients

favipiravir as adjunct ('add on') to supportive care, in comparison to placebo with supportive care, in the acute treatment of patients who have tested positive for SARS-CoV-2 and presenting with moderate to

SARS
pao2
respiratory distress
oropharyngeal
nasopharyngeal swab
  • 27 views
  • 24 Sep, 2020
  • 2 locations
Imatinib in Acute Ischaemic Stroke

A clinical trial comparing treatment with Imatinib to placebo when administered within 8 hours of stroke onset for 6 days, in addition to conventional stroke treatment after acute ischaemic stroke.

  • 16 views
  • 20 Sep, 2020
  • 26 locations
Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine Pain

Clinical study to determine the responder rate of the TheraNova Migraine Treatment System to that of a sham control treatment.

  • 0 views
  • 14 Oct, 2020
  • 1 location
IM Ketorolac vs Cambia for the Acute Treatment of Severe Migraine

This research will be conducted to see if the oral drug Cambia is as effective in relieving severe migraine headaches as the injectable drug ketorolac.

headache
acute treatment
  • 0 views
  • 08 Nov, 2020
  • 1 location
ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate

Adenocorticotrophic Hormone provides safe and effective treatment to induce disease remission in rheumatoid arthritis patients with active disease due to an inadequate response to methotrexate.

methotrexate
remission
  • 82 views
  • 07 Nov, 2020
  • 2 locations